What is the pregnancy risk for a patient with a normal maternal echocardiogram who has a history of coronary stents and coronary artery bypass grafting (CABG)?

Pregnancy Risk Assessment in Women with Prior Coronary Stents and CABG

A patient with a normal maternal echocardiogram and history of coronary stents and CABG can be considered for pregnancy, but remains at intermediate-to-high risk for serious maternal cardiac complications, with mortality risk of 5-10% if acute coronary syndrome occurs during pregnancy. 1

Risk Stratification Framework

The ESC guidelines explicitly state that "pregnancy may be considered in women with known coronary artery disease in the absence of residual ischaemia and clinical signs of LV dysfunction." 1 Your patient meets these criteria with a normal echocardiogram, placing her in a potentially acceptable risk category—but this does not mean low risk.

Key Maternal Risks

Acute coronary events during pregnancy carry substantial mortality:

• Maternal mortality after ACS during pregnancy: 5-10%, highest in the peripartum period 1
• Risk of new or progressive angina: 18% during pregnancy 2
• Composite cardiac events (cardiac arrest, ACS/MI, arrhythmia, heart failure): 10% 2

Women with underlying coronary atherosclerosis face the highest risk:

• Ischemic complications occur in 50% of women with coronary atherosclerosis versus only 10% in those without 2
• This is critical since your patient has documented CAD requiring both stents and CABG

Pregnancy-Specific Coronary Risks

The physiological changes of pregnancy create a perfect storm for coronary events:

• Hemodynamic stress: 40% increase in cardiac output, peaking in third trimester 3
• Prothrombotic state: Increased clotting factors and reduced fibrinolysis 3
• Spontaneous coronary dissection: More prevalent in pregnant than non-pregnant women, especially around delivery 1
• Timing vulnerability: ACS can occur at any gestational stage, but thrombi and dissections peak peripartum 1

Fetal and Obstetric Risks

Beyond maternal cardiac risk, expect:

• Adverse obstetric events: 16% (gestational hypertension, postpartum hemorrhage) 3
• Fetal/neonatal complications: 30% (preterm birth, intrauterine growth restriction) 3, 2
• Fetal mortality and prematurity if maternal ACS occurs before delivery 1

Critical Pre-Pregnancy Requirements

Before proceeding with pregnancy, the following must be completed:

1. Comprehensive cardiac risk assessment including:

   • Stress testing to exclude residual ischemia (exercise ECG or stress echo—avoid radionuclide studies) 1
   • Coronary angiography if any concern for progression or in-stent restenosis
   • Assessment of cardiovascular risk factors (smoking, hypertension, diabetes, hyperlipidemia) 1

2. Medication optimization:

   • Discontinue ACE inhibitors, ARBs, and renin inhibitors immediately—these are contraindicated in pregnancy 1, 3
   • Continue β-blockers and low-dose aspirin (considered relatively safe) 1
   • Clopidogrel safety unknown; use only when strictly necessary and for shortest duration 1

3. Multidisciplinary planning in a Cardio-Obstetrics Program (COP) 3

Management During Pregnancy

If pregnancy proceeds, close surveillance is mandatory:

• Serial cardiac assessments throughout pregnancy
• Immediate access to interventional cardiology center
• If ACS occurs: Primary PCI is preferred over thrombolysis 1
• Use bare metal stents only if intervention needed—drug-eluting stents require prolonged dual antiplatelet therapy and safety is unknown 1
• Avoid ergometrine postpartum (causes coronary vasospasm) 1

Common Pitfalls to Avoid

1. False reassurance from normal echo: LV function is only one component; residual ischemia and atherosclerotic burden matter more 2
2. Underestimating peripartum risk: The highest risk period is around delivery and early postpartum 1
3. Medication errors: ACE inhibitors/ARBs must be stopped before conception 1, 3
4. Delayed ACS diagnosis: Chest pain symptoms may be attributed to pregnancy; maintain high index of suspicion 1

Risk Classification

Using the Canadian CARPREG II framework and mWHO classification system, this patient would likely fall into WHO Class III (significantly increased risk) or potentially Class IV (extremely high risk) depending on functional status and extent of coronary disease 3. The presence of prior MI requiring both stenting and CABG suggests extensive disease.

Bottom line: This is NOT a low-risk pregnancy. Proceed only after thorough pre-pregnancy evaluation confirms absence of residual ischemia, with full understanding of substantial maternal and fetal risks, and commitment to intensive monitoring in a specialized cardio-obstetrics center.